EntroGen News & Events
Join Us At AMP 2022
Nov 1-5, 2022
read moreMGMT Webinar
January 27, 2022 11am PST | 2pm EST
read moreEntroGen Launches NGS Targeted Hotspot Panel
January 13, 2020
read moreUSC and EntroGen to study clinical utility of EntroGen’s liquid biopsy solutions for lung cancer
Los Angeles, California – June 12, 2017 — Today EntroGen Inc. announced that it has entered into a clinical collaboration with University of Southern California Norris Comprehensive Cancer Center to conduct an observational study to determine the clinical utility of... read moreEntroGen announces CE-IVD marking of its BRCA Complete™ BRCA1/BRCA2 sequencing kit
Los Angeles, California – May 17, 2017 — Today EntroGen Inc. announced CE-IVD marking of its BRCA Complete™ kit, a targeted next generation sequencing (NGS) panel for BRCA1 and BRCA2 exome sequencing on Illumina® MiniSeq, MiSeq, and NextSeq platforms. BRCA Complete™... read moreEntroGen announces CE-IVD marking of its comprehensive Colorectal Cancer DNA panel and Thyroid Cancer kits
Los Angeles, California – March 20, 2017 — Today EntroGen Inc. announced CE-IVD marking of its Colorectal Cancer Panel (CRC), Thyroid Cancer Mutation Analysis kit (THDNA), and Thyroid Cancer Fusion Gene Detection kit (THRNA). The CRC panel is a highly multiplexed... read moreEntroGen releases BRCA Complete™ for targeted BRCA1/BRCA2 sequencing
Los Angeles, California – March 20, 2017 — Today EntroGen, Inc. has launched BRCA Complete™: a targeted next generation sequencing (NGS) panel for BRCA1 and BRCA2 exome sequencing on Illumina® MiniSeq, MiSeq, and NextSeq platforms. BRCA Complete™ is a full solution... read moreEntroGen Launches Multiplexed Leukemia Translocation Panel
November 16, 2016
read moreEntroGen announces immediate availability of its comprehensive Colorectal Cancer Mutation Detection Panel
October 3, 2016
read moreEntroGen Newsletter
Receive quarterly updates on EntroGen news and products.
